Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline Solution for AKI Prevention After Heart Transplantation
NCT05909150Phase 2Recruiting
- Start
- Nov 2023
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial of sodium chloride in acute kidney injury (AKI) (2 arms). Primary endpoint: Prevention of acute kidney injury at 7 days. Started Nov 2023; status: recruiting.
02
Drugs
sodium chloride
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05909150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05909150.